ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.450,24
-0,15%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4641
0,42%
Bitcoin
64.827,98
-0,48%
Brent Oil
84,765
-0,02%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSXV
  6. Waverley Pharma Inc (WAVE)

  7. Waverley Pharma Inc (WAVE) Notícias

WAVE

Waverley Pharma (WAVE)

Waverley Pharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSXV:WAVE
DataHoraFonteTítuloCódigoCompanhia
30/04/202421:08PR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
22/11/202319:00PR Newswire (Canada)Waverley Pharma Announces Changes to Board of DirectorsTSXV:WAVEWaverley Pharma Inc
20/03/202308:55PR Newswire (Canada)Waverley Pharma Provides Business UpdateTSXV:WAVEWaverley Pharma Inc
11/01/202309:55PR Newswire (Canada)Waverley Pharma Provides Update on its PARP-1 Inhibitor ProgramTSXV:WAVEWaverley Pharma Inc
05/08/202109:05PR Newswire (Canada)Waverley Pharma Announces $3,000,000 Credit FacilityTSXV:WAVEWaverley Pharma Inc
27/05/202109:05PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS EnglandTSXV:WAVEWaverley Pharma Inc
18/01/202110:40PR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS ScotlandTSXV:WAVEWaverley Pharma Inc
12/11/202014:04PR Newswire (Canada)Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United StatesTSXV:WAVEWaverley Pharma Inc
23/09/202009:20PR Newswire (Canada)Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)TSXV:WAVEWaverley Pharma Inc
08/09/202011:13PR Newswire (Canada)Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the Un...TSXV:WAVEWaverley Pharma Inc
25/08/202009:15PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in ItalyTSXV:WAVEWaverley Pharma Inc
30/07/202009:25PR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European CountriesTSXV:WAVEWaverley Pharma Inc
25/06/202009:15PR Newswire (Canada)Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Syn...TSXV:WAVEWaverley Pharma Inc
28/04/202017:53PR Newswire (Canada)Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial StatementsTSXV:WAVEWaverley Pharma Inc
03/02/202010:15PR Newswire (Canada)Waverley Pharma Announces Appointment of New President and CEOTSXV:WAVEWaverley Pharma Inc
08/01/202019:09PR Newswire (Canada)Waverley Pharma Announces Executive Leadership ChangesTSXV:WAVEWaverley Pharma Inc
17/12/201910:00PR Newswire (Canada)Waverley Pharma Announces Grant of Marketing Authorization in the United Kingdom for ErlotinibTSXV:WAVEWaverley Pharma Inc
11/03/201909:25PR Newswire (Canada)Waverley Pharma Provides Market Update and Fiscal 2018 Preliminary RevenueTSXV:WAVEWaverley Pharma Inc
18/12/201811:25PR Newswire (Canada)Waverley Pharma Announces Distribution Agreement and First Sale of Generic Oncology Products in the United KingdomTSXV:WAVEWaverley Pharma Inc
23/07/201809:35PR Newswire (Canada)Waverley Pharma Announces Resignation of CEO and Appointment of New CEOTSXV:WAVEWaverley Pharma Inc
27/06/201809:35PR Newswire (Canada)Waverley Pharma Announces Filing of Two Abbreviated New Drug Applications in the United StatesTSXV:WAVEWaverley Pharma Inc
25/06/201809:30PR Newswire (Canada)Waverley Pharma Announces Acquisition of two Generic Oncology Products Currently Marketed in the United KingdomTSXV:WAVEWaverley Pharma Inc
17/04/201809:30PR Newswire (Canada)Waverley Pharma Announces Filing of its Second Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
12/03/201810:00PR Newswire (Canada)Waverley Pharma Announces Filing of Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
27/10/201712:01PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - WAVE (anciennement BUFF.P)TSXV:WAVEWaverley Pharma Inc
27/10/201711:59PR Newswire (Canada)IIROC Trading Resumption - WAVE (Formerly BUFF.P)TSXV:WAVEWaverley Pharma Inc
 Apresentando as notícias mais relevantes sobre:TSXV:WAVE

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
HAGA3
HAGA ON
BOV
COGN3
COGNA ON
BOV
SGPS3
SPRINGS ON
BOV
HBOR3
HELBOR ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
OIBR3
OI ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
PRIO3
PETRORIO ON
BOV
RCSL4
RECRUSUL PN
BOV
TELB4
TELEBRAS PN
BOV
DASA3
DASA ON
BOV
TECN3
TECHNOS ON
BOV
LIGT3
LIGHT ON
BOV
VIVR3
VIVER ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados